TrialThe Journal of infectious diseases2015

Infant HIV type 1 gp120 vaccination elicits robust and durable anti-V1V2 immunoglobulin G responses and only rare envelope-specific immunoglobulin A responses.

Genevieve G Fouda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.